PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING
Abstract
A properly conducted pharmacoeconomic study and its results are a new element in the body of evidence for drugs recently introduced into clinical practice. Utilization of pharmacoeconomic analysis results as a new instrument in pharmaceutical marketing lets marketing specialists know what information to convey to health care decision makers and how to bring this information full, correct, and easy to understand.
About the Authors
M. V. Protsenko
The First MSMU named after I.M. Sechenov
Russian Federation
Department of Medicinal maintenance and pharmacoeconomics,
Russian Federation
Department of Medicinal maintenance and pharmacoeconomics,
N. I. Koroleva
The First MSMU named after I.M. Sechenov
Russian Federation
Department of Medicinal maintenance and pharmacoeconomics,
Russian Federation
Department of Medicinal maintenance and pharmacoeconomics,
Review
For citations:
Protsenko M.V., Koroleva N.I. PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2012;5(1):10-12. (In Russ.)
Views: 1076
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 